By: John DeFosse FRIED FRANK, HARRIS, SHRIVER & JACOBSON LLP THIS ARTICLE EXPLAINS THE STRATEGIC AND PRACTICAL considerations associated with filing a motion to dismiss claims of patent infringement under Rule 12(b)(6) of the Federal Rules of Civil...

By: Stephen E. Reynolds and Nicole R. Woods ICE MILLER LLP In response to the increased concern surrounding cybersecurity, the Association of Corporate Counsel (ACC) has released the Model Information Protection and Security Controls for Outside Counsel...

By: Celeste Mitchell-Byars, LEXIS PRACTICAL GUIDANCE President Biden recently signed Executive Order 14030, Climate-Related Financial Risk (May 20, 2021) (Executive Order) 1 to address the climate-related financial risks of federal programs. The Executive...

By: Michael Furrow , DLA Piper, and Whitney Meier , Venable LLP The Biologics Price Competition and Innovation Act (BPCIA) provides an abbreviated pathway for companies to bring biologic drugs to market that are biosimilar to previously approved branded...

By: The Practical Guidance Tax Team This article discusses the Consolidated Appropriations Act (the Act), passed by the House and Senate on December 21, 2020, and signed by President Trump on December 27, 2020. The Act pairs a roughly $900 billion novel...